Jessica Ponder

1.0k total citations
16 papers, 424 citations indexed

About

Jessica Ponder is a scholar working on Molecular Biology, Cancer Research and Cell Biology. According to data from OpenAlex, Jessica Ponder has authored 16 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Cancer Research and 6 papers in Cell Biology. Recurrent topics in Jessica Ponder's work include Aldose Reductase and Taurine (6 papers), Sesquiterpenes and Asteraceae Studies (6 papers) and Natural product bioactivities and synthesis (5 papers). Jessica Ponder is often cited by papers focused on Aldose Reductase and Taurine (6 papers), Sesquiterpenes and Asteraceae Studies (6 papers) and Natural product bioactivities and synthesis (5 papers). Jessica Ponder collaborates with scholars based in United States, Hungary and India. Jessica Ponder's co-authors include Daniel V. LaBarbera, J. Mark Petrash, Craig T. Jordan, Kun‐Che Chang, Peter A. Crooks, Palla Suryanarayana, Puppala Muthenna, G. Bhanuprakash Reddy, Narsimha Reddy Penthala and Michael J. Borrelli and has published in prestigious journals such as PLoS ONE, Journal of Controlled Release and Journal of Medicinal Chemistry.

In The Last Decade

Jessica Ponder

16 papers receiving 418 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jessica Ponder United States 12 208 96 81 79 49 16 424
Huayang Pan China 11 203 1.0× 65 0.7× 45 0.6× 74 0.9× 15 0.3× 18 489
Ling-Hua Zeng Canada 12 263 1.3× 136 1.4× 53 0.7× 49 0.6× 23 0.5× 22 616
Karvannan Kanchana China 9 314 1.5× 65 0.7× 72 0.9× 43 0.5× 37 0.8× 22 548
Usman Ghani Saudi Arabia 13 365 1.8× 236 2.5× 96 1.2× 68 0.9× 172 3.5× 24 838
Shitang Ma China 14 206 1.0× 106 1.1× 25 0.3× 77 1.0× 24 0.5× 53 537
Laurie L. McLeod United States 8 240 1.2× 60 0.6× 50 0.6× 25 0.3× 55 1.1× 8 511
Kyriaki Pegklidou Greece 8 172 0.8× 124 1.3× 224 2.8× 16 0.2× 63 1.3× 9 499
Akihiro Sekiguchi Japan 10 225 1.1× 173 1.8× 32 0.4× 29 0.4× 49 1.0× 15 528
Rosario I. Bello Spain 13 390 1.9× 60 0.6× 36 0.4× 29 0.4× 17 0.3× 20 633

Countries citing papers authored by Jessica Ponder

Since Specialization
Citations

This map shows the geographic impact of Jessica Ponder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jessica Ponder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jessica Ponder more than expected).

Fields of papers citing papers by Jessica Ponder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jessica Ponder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jessica Ponder. The network helps show where Jessica Ponder may publish in the future.

Co-authorship network of co-authors of Jessica Ponder

This figure shows the co-authorship network connecting the top 25 collaborators of Jessica Ponder. A scholar is included among the top collaborators of Jessica Ponder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jessica Ponder. Jessica Ponder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Penthala, Narsimha Reddy, Meenakshisundaram Balasubramaniam, Poornima Bhat‐Nakshatri, et al.. (2021). Antitumor properties of novel sesquiterpene lactone analogs as NFκB inhibitors that bind to the IKKβ ubiquitin-like domain (ULD). European Journal of Medicinal Chemistry. 224. 113675–113675. 8 indexed citations
2.
Ye, Haobin, Mohammad Minhajuddin, Anna Krug, et al.. (2020). The Hepatic Microenvironment Uniquely Protects Leukemia Cells through Induction of Growth and Survival Pathways Mediated by LIPG. Cancer Discovery. 11(2). 500–519. 19 indexed citations
3.
Yang, Chunyan, Fangfang Chen, Ping Ren, et al.. (2020). Delivery of a model lipophilic membrane cargo to bone marrow via cell-derived microparticles. Journal of Controlled Release. 326. 324–334. 5 indexed citations
4.
Ponder, Jessica, Meenakshisundaram Balasubramaniam, Poornima Bhat‐Nakshatri, et al.. (2018). MMB triazole analogs are potent NF-κB inhibitors and anti-cancer agents against both hematological and solid tumor cells. European Journal of Medicinal Chemistry. 157. 562–581. 38 indexed citations
5.
Ponder, Jessica, et al.. (2017). Indole carboxylic acid esters of melampomagnolide B are potent anticancer agents against both hematological and solid tumor cells. European Journal of Medicinal Chemistry. 136. 393–405. 27 indexed citations
6.
Ponder, Jessica, et al.. (2017). Succinamide derivatives of melampomagnolide B and their anti-cancer activities. Bioorganic & Medicinal Chemistry. 25(14). 3694–3705. 17 indexed citations
7.
Chen, Zheng, et al.. (2016). Identification of a melampomagnolide B analog as a potential lead molecule for treatment of acute myelogenous leukemia. Bioorganic & Medicinal Chemistry. 25(3). 1235–1241. 11 indexed citations
8.
Tyagi, Vikas, Hanan Alwaseem, Kristen M. O’Dwyer, et al.. (2016). Chemoenzymatic synthesis and antileukemic activity of novel C9- and C14-functionalized parthenolide analogs. Bioorganic & Medicinal Chemistry. 24(17). 3876–3886. 34 indexed citations
9.
Ponder, Jessica, et al.. (2015). Dimers of Melampomagnolide B Exhibit Potent Anticancer Activity against Hematological and Solid Tumor Cells. Journal of Medicinal Chemistry. 58(22). 8896–8906. 32 indexed citations
10.
Chang, Kun‐Che, Jessica Ponder, Daniel V. LaBarbera, & J. Mark Petrash. (2014). Aldose Reductase Inhibition Prevents Endotoxin-Induced Inflammatory Responses in Retinal Microglia. Investigative Ophthalmology & Visual Science. 55(5). 2853–2853. 36 indexed citations
11.
Li, Linfeng, Kun‐Che Chang, Biehuoy Shieh, et al.. (2013). Design of an Amide N-Glycoside Derivative of β-Glucogallin: A Stable, Potent, and Specific Inhibitor of Aldose Reductase. Journal of Medicinal Chemistry. 57(1). 71–77. 44 indexed citations
12.
Chang, Kun‐Che, Brian Laffin, Jessica Ponder, et al.. (2013). Beta-glucogallin Suppresses Lipopolysaccharide-induced Inflammatory Markers by Aldose Reductase Inhibition in Murine Macrophages and Ocular Tissues. 54(15). 2928–2928. 1 indexed citations
13.
Chang, Kun‐Che, Brian Laffin, Jessica Ponder, et al.. (2012). Beta-glucogallin reduces the expression of lipopolysaccharide-induced inflammatory markers by inhibition of aldose reductase in murine macrophages and ocular tissues. Chemico-Biological Interactions. 202(1-3). 283–287. 45 indexed citations
14.
Muthenna, Puppala, Jessica Ponder, Palla Suryanarayana, et al.. (2012). The Isolation and Characterization of β-Glucogallin as a Novel Aldose Reductase Inhibitor from Emblica officinalis. PLoS ONE. 7(4). e31399–e31399. 89 indexed citations
15.
Ponder, Jessica, et al.. (2012). Synthesis and characterization of β-glucogallin as an aldose reductase inhibitor from Emblica officinalis. Planta Medica. 78(11). 3 indexed citations
16.
Ponder, Jessica, Byong Hoon Yoo, Qun Li, et al.. (2011). Neoamphimedine Circumvents Metnase-Enhanced DNA Topoisomerase IIα Activity Through ATP-Competitive Inhibition. Marine Drugs. 9(11). 2397–2408. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026